MIDAS, Inc. (NY:MDS)

8.19

0.05 (0.61%)

MIDAS, Inc. (NY:MDS) Delayed :
Previous Close	$8.24	52 Week High	$11.73
Open	$8.35	52 Week Low	$6.03
Day High	$8.35	P/E	21.00
Day Low	$8.11	EPS	$0.39
Volume	59,587
More MDS Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
MDZ	9	DHR	2
PKI	1

View All Entities

Dec 7, 2009 11:07 AM Midas (MDS) Extends $125M Revolving Credit Facility with Several Banks
Jun 19, 2009 12:26 PM Midas (MDS) Shares Slide as CL King Downgrades to Neutral
Mar 12, 2009 07:45 AM MDS Inc. (MDZ) Misses Street's Q1 Views
Mar 6, 2009 10:11 AM BB&T Capital Downgrades Midas (MDS) to Hold
Mar 5, 2009 09:33 AM Midas (MDS) Tops Q4 Views

Feb 5, 2010 08:00AM MDS Nordion's TheraSphere(R) for Unresectable Liver Cancer (HCC) Now Covered by Two Large U.S. Insurers
Feb 1, 2010 08:05AM MDS Inc. Announces Appointment of William D. Anderson as Chair of Board of Directors
Feb 1, 2010 08:00AM MDS Inc. Completes Divestiture of MDS Analytical Technologies
Jan 27, 2010 02:59PM MDS Receives U.S. Federal Trade Commission Provisional Regulatory Approval for Sale of MDS Analytical Technologies
Jan 26, 2010 08:31AM MDS Files 2009 Annual Reports

Sep 2, 2009 12:45 PM Danaher (DHR) makes acquisition, cuts jobs
Jul 9, 2009 10:02 AM FDA Calendar Updates: Rigel Pharma, GlaxoSmithKline, Eisai, SuperGen
Mar 20, 2009 07:00 AM Midas, Inc. Q4 2008 Earnings Call Transcript
Jun 3, 2008 04:05 PM Midas F1Q08 (Quarter End 03/29/2008) Earnings Call Transcript
Jun 2, 2008 05:00 PM Earnings expectations: Take-Two, Lululemon, Williams-Sonoma, Toll Bros. and others

Jan 29, 2010 02:58PM Form SC 13G MIDAS INC Filed by: BlackRock Inc.
Jan 26, 2010 02:31PM Form SC 13G MIDAS INC Filed by: Cumberland Private Wealth Management Inc.
Jan 26, 2010 06:16AM Form 8-K MIDAS INC For: Jan 25
Dec 29, 2009 11:30AM Form SC 13D/A MIDAS INC Filed by: GAMCO INVESTORS, INC. ET AL
Dec 17, 2009 03:05PM Form SC 13D/A MIDAS INC Filed by: GAMCO INVESTORS, INC. ET AL

No comments are currently available.